Skip to content
healthcare.dev
Get a free key

Erythromycin ethylsuccinate

NDC 71209-102, Erythromycin ethylsuccinate, for suspension, from Cadila Pharmaceuticals Limited.

Product NDC
71209-102
Status
Listed
Labeler
Cadila Pharmaceuticals Limited
Dosage form
FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216212
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71209-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERYTHROMYCIN ETHYLSUCCINATE200 mg/5mL

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]

Package NDCNDC-11Package
71209-102-2171209010221100 mL in 1 BOTTLE (71209-102-21)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/db70798e-5e07-41d6-afe9-82c272bc5cc0

Use it

Look up 71209-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71209-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71209-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.